EICHOR
● Recruiting
A Study to Test Whether Nerandomilast Helps People With Systemic Sclerosis
Condition: Systemic Sclerosis · Sponsor: Boehringer Ingelheim
About this study
Nerandomilast is being developed to help people with systemic sclerosis by potentially improving symptoms and slowing disease progression. This study is open to adults who are at least 18 years old and have systemic sclerosis (SSc). People can join the study if they have limited or diffuse cutaneous SSc with disease onset within 7 years of the first non-Raynaud's symptom. The purpose of this study is to find out whether a medicine called nerandomilast helps people with systemic sclerosis. This study also aims to find out how well nerandomilast is tolerated in people with systemic sclerosis. Participants are put into 2 groups randomly, which means by chance. One group takes nerandomilast tablets and the other group takes placebo tablets. Placebo tablets look like nerandomilast tablets but do not contain any medicine. Participants take the tablets twice a day. Participants are in the study for 1 to about 4 years. During this time, they visit the study site regularly and get phone calls from the site staff. During study visits participants regularly have blood samples taken and doctors check changes in skin thickening, lung function, and internal organs, overall health and the safety and tolerability of study treatment in people with SSc. The results are compared between the groups to see whether the treatment works. The doctors also regularly check participants' health and take note of any unwanted effects.
This description comes directly from the study's public registry record.
Talk to the study team
Boehringer Ingelheim · 1-800-243-0127 · clintriage.rdg@boehringer-ingelheim.com
Always discuss trial participation with your own doctor first.
Locations (241)
| University of Alabama at Birmingham | Birmingham, Alabama, United States | Not Yet Recruiting |
| Banner - University Medicine Rheumatology Clinic | Phoenix, Arizona, United States | Not Yet Recruiting |
| Arizona Arthritis and Rheumatology Associates - Paradise Valley | Scottsdale, Arizona, United States | Not Yet Recruiting |
| University of California Los Angeles | Los Angeles, California, United States | Not Yet Recruiting |
| Paradigm Clinical Research - San Diego | San Diego, California, United States | Recruiting |
| Stanford University School of Medicine | Stanford, California, United States | Not Yet Recruiting |
| Medvin Clinical Research-Whittier-69033 | Whittier, California, United States | Recruiting |
| University of Colorado Denver | Aurora, Colorado, United States | Not Yet Recruiting |
| Georgetown University | Washington D.C., District of Columbia, United States | Not Yet Recruiting |
| Millennium Research - Ormond Beach | Ormond Beach, Florida, United States | Not Yet Recruiting |
| Integral Rheumatology and Immunology Specialist | Plantation, Florida, United States | Not Yet Recruiting |
| BioResearch Partner - South Miami | South Miami, Florida, United States | Recruiting |
+ 229 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.